Recruiting NA INTERVENTIONAL 2-arm
NCT07380854
Thyroid Hormone Replacement After Coronary Artery Bypass Grafting for Patients With Subclinical Hypothyroidism (RepleniSH)
Sponsor: Seoul National University Bundang Hospital
Conditions
Subclinical Hypothyroidism
Interventions
levothyroxine
Updated 1 time since 2026 Last updated: Jan 24, 2026 Started: Feb 27, 2022 Primary completion: Feb 26, 2032 Completion: Feb 26, 2037
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07380854, this NA trial focuses on Subclinical Hypothyroidism and remains actively recruiting participants. Sponsored by Seoul National University Bundang Hospital, it has been updated 1 time since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Seoul National University Bundang Hospital
Data source: Seoul National University Bundang Hospital
For direct contact, visit the study record on ClinicalTrials.gov .